Research Topics
Genomes and GenesSpecies | Michael D SouthallSummaryAffiliation: Johnson and Johnson Pharmaceutical Research and Development Country: USA Publications
| Collaborators
|
Detail Information
Publications
Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytesMichael D Southall
Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
J Pharmacol Exp Ther 304:217-22. 2003..Our results suggest that VR1 expression in keratinocytes may have a role in the inflammation that occurs secondary to epidermal damage or insult, and thus may function as a sensor for noxious cutaneous stimulation...
The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell linesTao Li
Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
J Biol Chem 278:16614-21. 2003..These studies provide evidence for a novel pathway whereby the epidermal PAF-R can augment chemotherapy-induced apoptotic effects through an NF-kappaB-dependent process...
Identification of platelet-activating factor acetylhydrolase II in human skinMariangela Marques
Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana 46202, U S A
J Invest Dermatol 119:913-9. 2002....
Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthomaSteven D Billings
Departments of Pathology and Laboratory Medicine and Dermatology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Am J Pathol 163:2451-8. 2003..The HaCaT-NIE cells formed thin tumors resembling conventional SCC. The HaCaT-AR cells formed rapidly growing tumors with AR expression similar to KA. HaCaT-AR cells may represent a new system for the further evaluation of KA...
Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiationQiwei Zhang
Department of Dermatology, Indiana University School of Medicine, Indinapolis, Indiana 46202, USA
J Biol Chem 280:73-9. 2005..These studies demonstrated that epithelial cells contain a functional PPAR gamma system, and this system is a target for UVB through the production of novel oxidatively modified endogenous phospholipids...
The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathwaySilvio A Marques
Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
J Pharmacol Exp Ther 300:1026-35. 2002..In summary, these studies provide a mechanism whereby the PAF-R can exert proliferative effects through the activation of the EGF-R...
Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damageGopal K Marathe
Human Molecular Biology and Genetics Program, University of Utah, Salt Lake City 84112 5330, USA
J Biol Chem 280:35448-57. 2005..PAF signaling may participate in the cutaneous inflammation that occurs during photo-aggravated dermatoses...
Hsp27 regulates pro-inflammatory mediator release in keratinocytes by modulating NF-kappaB signalingRuna Sur
Preclinical Pharmacology, Johnson and Johnson Skin Research Center, CPPW, a Unit of Johnson and Johnson Consumer Companies Inc, Skillman, New Jersey 08558, USA
J Invest Dermatol 128:1116-22. 2008..Thus, Hsp27 plays a protective role in regulating inflammatory responses in skin...
Anti-inflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathwayRuna Sur
Preclinical Pharmacology, Johnson and Johnson Skin Research Center, CPPW, a unit of Johnson and Johnson Consumer Companies, Inc, Skillman, New Jersey 08558, USA
J Invest Dermatol 128:336-44. 2008..Biochemical analysis of tissue biopsies revealed increase in PGE2 levels in sertaconazole-treated mice. Thus, activation of the p38-COX-2-PGE2 pathway by agents such as sertaconazole provides anti-inflammatory therapeutic benefits...
